Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.402 SEK | -16.42% | -14.29% | -54.32% |
Apr. 09 | Biosergen to Issue New Units as Compensation Under Rights Issue | MT |
Mar. 27 | Biosergen Raises SEK26.4 Million via Rights Issue | MT |
Business Summary
Number of employees: 3
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tine Kold Olesen
CEO | Chief Executive Officer | - | - |
Niels Laursen
DFI | Director of Finance/CFO | 68 | - |
Peder Andersen
CTO | Chief Tech/Sci/R&D Officer | 72 | - |
Leila Malik
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 20-12-31 | |
Achim Kaufhold
BRD | Director/Board Member | 66 | 20-12-31 |
Chairman | 65 | 14-12-31 | |
Marianne Kock
BRD | Director/Board Member | 69 | 20-12-31 |
Director/Board Member | 57 | 20-12-31 | |
Director/Board Member | 61 | 20-12-31 | |
Director/Board Member | - | 20-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 50,685,863 | 27,820,757 ( 54.89 %) | 0 | 54.89 % |
Company contact information
Sector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-54.32% | 6.1M | |
-3.07% | 102B | |
+1.68% | 96.07B | |
-1.80% | 21.66B | |
-17.59% | 20.77B | |
-6.91% | 18.53B | |
-40.31% | 16.91B | |
-27.94% | 13.79B | |
+0.07% | 13.33B | |
+19.49% | 10.94B |
- Stock Market
- Equities
- BIOSGN Stock
- Company Biosergen AB